ITI-1284 is named as an intervention in 4 current clinical trials in our USA register. 4 are recruiting patients now. The most common phase is Phase 2. The lead sponsor is Intra-Cellular Therapies, Inc. The most-studied condition is Generalized Anxiety Disorder.
| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
A Study to Asses Safety and Tolerability of ITI-1284 Given Alone or as an Additional Treatment in Participants With Generalized Anxiety Disorder (GAD)
NCT07807865 · ClinicalTrials.gov ↗ · Generalized Anxiety Disorder
|
Phase 3 | Recruiting | Intra-Cellular Therapies, Inc. | USA |
|
Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder
NCT06480383 · ClinicalTrials.gov ↗ · Generalized Anxiety Disorder
|
Phase 2 | Recruiting | Intra-Cellular Therapies, Inc. | USA |
|
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
NCT06540833 · ClinicalTrials.gov ↗ · Psychotic Disorders, Alzheimer Disease
|
Phase 2 | Recruiting | Intra-Cellular Therapies, Inc. | USA |
|
Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder
NCT06701903 · ClinicalTrials.gov ↗ · Generalized Anxiety Disorder
|
Phase 2 | Recruiting | Intra-Cellular Therapies, Inc. | USA |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Lead sponsor | Trials |
|---|---|
| Intra-Cellular Therapies, Inc. | 4 |
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in USA | 4 | 4 |
A trial with sites in more than one country appears in each of those registers.
4 current trials in our USA register name ITI-1284 as a drug or biological intervention, as of the registry sync on 25 September 2026. Completed and withdrawn studies are not counted.
Yes. 4 of the 4 trials are recruiting: 4 with sites in USA. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
The lead sponsor is Intra-Cellular Therapies, Inc. The number in brackets is how many trials each organisation leads.
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how ITI-1284 works or whether it is effective, and it is not medical advice.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how ITI-1284 works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists ITI-1284 (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 25 Sep 2026.